Self-reported use of cannabidiol as a substitute or adjunct for approved medications
Abstract Objective: To assess the prevalence of CBD use among US adults, identify the health conditions for which CBD is…
Eric C. Leas
Prevalence and reasons for using cannabidiol, delta-8 tetrahydrocannabinol, cannabinol, cannabigerol, and hexahydrocannabinol among US adults
Abstract Background: Since the passage of the 2018 US Farm Bill there has been a market for cannabinoid products derived…
Waldo: Automated discovery of adverse events from unstructured self reports
Abstract Adverse event (AE) detection is labor-intensive and costly given the task is to find rare events. Automated solutions to…
Derived cannabinoid product availability among online vape shops
Abstract Nearly 36% of vape shops in San Diego, California sold derived cannabinoid products. About 27% of vape shops sold…
State Cannabis and Psychedelic Legislation and Microdosing Interest in the US
Abstract Importance: Despite growing interest in psychedelics, there is a lack of routine population-based surveillance of psychedelic microdosing (taking “subperceptual”…
Self-reported adverse events associated with ∆8-Tetrahydrocannabinol (Delta-8-THC) Use
Abstract Background: There is an expanding unregulated market for a psychotropic compound called ∆8-Tetrahydrocannabinol (delta-8-THC) that is being derived from…
Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops
Abstract Vaping products containing cannabidiol (CBD), a cannabis-derived compound used in wellness products and available in all 50 US states,…
Self-reported Cannabidiol (CBD) Use for Conditions With Proven Therapies
Abstract This case series assesses whether individuals are using cannabidiol (CBD) to treat diagnosable conditions with proven therapies. Authors: Eric…
Trends in Internet Searches for Cannabidiol (CBD) in the United States
Abstract This cross-sectional study examines Google searches for cannabidiol (CBD) in the United States to gauge public interest in the…